Navigation Links
Sinovac Reports Unaudited First Quarter 2011 Financial Results
Date:5/13/2011

BEIJING, May 13, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.

First Quarter 2011 Financial Highlights

  • Sales increased 5.3% year-over-year to $4.7 million, compared to $4.4 million. Excluding H1N1 vaccine, sales rose 50% compared to the prior year period.

  • Cash and cash equivalents totaled $91.0 million as of March 31, 2011, compared to $101.6 million as of December 31, 2010.

  • Business Highlights

  • Sinovac has enrolled 168 healthy volunteers in three different groups (36 adults, 36 young children and 96 infants) in the Phase I clinical trial for EV71 vaccine. The inoculations with different dosages have been completed in the young children group and are underway in the infant group, which is expected to be completed in the next few weeks. The preliminary results showed good safety and tolerance profile without severe adverse reaction.

  • In April 2011, Sinovac submitted the application to the SFDA to commence clinical trials for its rubella vaccine.  

  • In April 2011, the Ministry of Agriculture (MOA) conducted the final GMP site inspection of Sinovac's animal rabies vaccine production plant in Tangshan Yian, which was conducted under the production mode.  The preliminary site inspection results were positive and are subject to a public notification period that ends on May 18, 2011, after which Tangshan Yian will apply for the GMP Certificate, the New Drug Certificate and the production license in advance of commercializing the vaccine.

  • Dr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "Following the adjustment to our sales strategy and sales team structure, our sales in China rebounded during t
    '/>"/>

    SOURCE Sinovac Biotech Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Sinovac Presents at Two Investor Conferences in May 2011
    2. Sinovac Files Annual Report on Form 20-F
    3. Sinovac Participates in UBS Greater China Healthcare Corporate Day
    4. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
    5. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
    6. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
    7. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
    8. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
    9. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
    10. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
    11. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
    (Date:5/22/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/3rthk2/latest ) ... Regulations on Pharmaceutical International Multi-Center Clinical Trials in ... This is first time in history, Chinese pharmaceutical ... clinical trials of drugs in China ... on March 1, 2015. The guidance provides an ...
    (Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that interim chief executive officer Howie Rosen ... chief financial officer Tim Morris will be ... the two presentations are as follows: Jefferies ...
    Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
    (Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers ... Florida City exactly five years to the day after the ... A large fire tore through the Branches United Methodist Church ... the middle of the night as neighbors, staff and Branches' ... even though it is suspected that the fire began accidentally. ...
    (Date:5/23/2015)... CA (PRWEB) May 23, 2015 Dr. David ... California, has just posted a new article to ... repair. As Dr Benvenuti explained in the fascinating ... enlarged plugs in their earlobes. , Known as “gauging,” the ... earlobe hole, which Dr. Benvenuti said will eventually stretch the ...
    (Date:5/23/2015)... May 23, 2015 On Wednesday, May ... “the company has been the target of a sophisticated ... of the company’s ongoing Information Technology (IT) security efforts ... , The most notable attack on health insurers ... Inc., the nation’s second largest health insurer, revealed that ...
    (Date:5/23/2015)... 2015 Manufacturers are now required to produce ... of 8.2. Experts in the field agree that the regulation ... The HSPF score is what miles per gallon is to ... unit. Although the minimum HSPF score has been raised to ... HSPF score north of 12. Indeed, the regulation was welcomed ...
    (Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
    Breaking Medicine News(10 mins):Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
    ... , Health Sector in Vanguard of Clean Energy Programs ... 3 In recent months, three U.S. hospitals signed energy contracts ... them with up to 10 percent clean energy. The green energy will ... is equivalent to taking 2,052 cars off the road or not burning ...
    ... PEMBROKE , Bermuda , Feb. 3 ... announced today that Theana Iordanou has,joined the company as ... responsible for managing profit & loss for the New York ... to,expand distribution and manage relationships with the brokerage community in,the ...
    ... levels of an inflammatory chemokine were significantly elevated ... obese, according to research conducted by scientists at ... They presented their data at the 5th Annual ... Studies have shown that obesity is correlated with ...
    ... cancer survivors live longer, questions arise about what kind of ... study from Case Western Reserve University,s Mandel School of Applied ... had more health problems as compared to a sample of ... Well-Being in Older Married Female Cancer Survivors," was published as ...
    ... , , ... Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award ... company to manufacture Active Pharmaceutical Ingredients (APIs). Adhering to Good ... tonnes of API, 8 million laminated aluminum tubes of dermatological ...
    ... new approach for the care of respiratory diseases report ... associated with improved outcomes in tests on mice with ... human embryonic stem cells (hESCs). Findings by investigators at ... are scheduled to appear in the March issue of ...
    Cached Medicine News:Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 2Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 3Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 4Health News:Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager 2Health News:Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager 3Health News:Older female cancer survivors have added health issues compared to their counterparts 2Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 2Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 3Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 4Health News:Experimental stem cell treatment arrests acute lung injury in mice, study shows 2
    ... Colorimetric Assay of ... and Low Molecular ... substrate CBS 31.39, ... purified bovine ATIII, ...
    Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
    Substrate Plasma for Factor IX Assay by STA© Analyzers. Freeze-dried human plasma from which factor IX has been removed by selective immuno-adsorption....
    Substrate Plasma for Factor XII Assay by STA© Analyzers. Freeze-dried human plasma lacking factor XII....
    Medicine Products: